Kamaliya et. al. : The Healer Journal January 2021; 2(1) 52 www.thehealerjournal.org l The healer l Volume 02 l Issue 01 l January 2021 www.thehealerjournal.org 52 Dr. Sangita Kamaliya PhD scholar Dept. of Shalakya Tantra, Institute of Teaching E-mail: sokamaliya@gmail.com Submitted: 07.11.2020 Received: 19.01.2021 Revised: 20.01.2021 Accepted: 25.01.2021 Access the article online Quick Responde Code www.thehealerjournal.org DOI: 10.51649/healer.20 Quality Control Evaluation of An Ayurvedic Herbomineral Compound – Mukkadi Bidalaka Sangita Kamaliya 1 , Neethu Kesavan 2 , D.B. Vaghela 3 3 ABSTRACT: Background: Mukkadi Bidalaka Yoga Timira (Diabetic Retinopathy). In present study, it has been used for Bidalaka Karma.Objective: Present study was designed to watch out on herbal and mineral drugs used in the preparation of Mukkadi Bidalaka Yoga to assess the quality, purity, safety Methods: Pharmacognostical study i.e. morphological characters, organoleptic characters and powder microscopy was done Results: Pharmacognostical characters of Mukkadi Bidalaka stone cell of Haritaki Bibhitaki, Scleroids, silica deposition of Amalaki, Parenchyma cells and starch grain of Haridra Daruharidra, Cork cells of Nimba, Brown content of Sariva, Trichome, oil globule of Usheera Lodhra and stone cells of Vata, Parenchyma cells and oil globule of Durva Girika Raktachandana. Pharmaceutical evaluation of Mukkadi Bidalaka Yoga showed results loss on drying at 110C 5.85 % w/w, pH value 6.0, water soluble extract 21.60% w/w, methanol soluble extract 14.28% w/w, Ash value 3% w/w acid insoluble ash 0.39% w/w. High Performance Thin Layer Chromatography result shows 9 spots at 254 nm and 7 spots at 366 nm. Conclusion Mukkadi Bidalaka Yoga was done. Pharmacognostical, physicochemical and HPTLC evaluation of prepared drug has been carried out. KEYWORDS: Diabetic Retinopathy, Mukkadi Bidalaka, Pharmacognostical, Standardization